Colony Bankcorp, Inc.
NYSE:CBANBanks - Regional
+$0.01 today
- Market cap
- $542.11M
- Beta
- 0.55
- P/E (TTM)
- 14.6
- EPS (TTM)
- $1.41
- Dividend yield
- 2.29%
Volume 0.25M
Average 0.31M
CBAN EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Colony Bankcorp, Inc.NYSE: CBAN
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) grows, but more slowly than its trailing trend
Q1 FY2026 EPS (Diluted) of $0.39 rose 2.6% year over year, behind the +11.9% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 7.1% from the prior quarter. Over 3 fiscal years it compounded at +11.7% a year.
Context
- EPS (Diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 1 analysts of $2.07 (+30.2%) for the fiscal year ending Dec 2026, a step up from the +16.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $0.39-7.1% QoQ
- Last fiscal yearDec 2025
- $1.59+16.9% YoY
- LTMMar 2026
- $1.6+11.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +2.6% | +4.3% | +1.7 pp |
| 1 year | +16.9% | +30.2% | +13.3 pp |
| 3-year CAGR | +11.7% | +18.6% | +6.8 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 1.59 USD
- Year-over-year change
- +16.9%
- 4-year CAGR
- -1.1%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.59 | +16.9% |
| FY2024 | 2024-12-31 | 1.36 | +9.7% |
| FY2023 | 2023-12-31 | 1.24 | +8.8% |
| FY2022 | 2022-12-31 | 1.14 | -31.3% |
| FY2021 | 2021-12-31 | 1.66 | — |
EPS (Diluted) vs competitors
How CBAN compares with its peers on the latest reported figures
- CBAN's LTM Mar 2026 EPS (Diluted) of $1.6 is the 9th highest of the 11 companies compared; the peer median is $2.57.
- Its year-over-year change of +11.9% is the 7th highest of 11, against a peer median of +18.0%.
- Over three fiscal years its annual growth of +11.7% compares with a peer median of +1.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $4.72 | -4.5% | +0.5% | |
| LTM Mar 2026 | $4.29 | -1.4% | +5.0% | |
| LTM Mar 2026 | $3.91 | +20.7% | +9.2% | |
| LTM Mar 2026 | $3.24 | +29.1% | -4.5% | |
| LTM Mar 2026 | $2.71 | +37.6% | -4.2% | |
| LTM Mar 2026 | $2.42 | +15.2% | +6.4% | |
| LTM Mar 2026 | $2.2 | -5.2% | +1.8% | |
| LTM Mar 2026 | $1.65 | +61.8% | +18.5% | |
| LTM Mar 2026 | $1.6 | +11.9% | +11.7% | |
| LTM Mar 2026 | $1.59 | +27.2% | -12.8% | |
| LTM Mar 2026 | $1.09 | -38.0% | -5.1% | |
| Peer median (excluding CBAN) | $2.57 | +18.0% | +1.1% | |
Competitors are the stored peer set for CBAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 106.88M | 126.56M | 160.55M | 176.62M | 186.11M |
| Cost of Revenue | 5.1M | 14.24M | 50.27M | 64.22M | 62.55M |
| Gross Profit | 101.78M | 112.33M | 110.28M | 112.4M | 123.56M |
| Gross Margin | 95.2% | 88.8% | 68.7% | 63.6% | 66.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 48.25M | 56.47M | 52.72M | 53.78M | 3.51M |
| Operating Expenses | 78.63M | 89.48M | 83.07M | 82.83M | 88.42M |
| Depreciation & Amortization | 8.63M | 11.63M | 8.7M | 8.13M | 93K |
| EBITDA | 31.78M | 34.48M | 35.92M | 37.7M | 35.14M |
| EBITDA Margin | 29.7% | 27.2% | 22.4% | 21.3% | 18.9% |
| Operating Income | 23.15M | 22.85M | 27.21M | 29.57M | 35.14M |
| Operating Margin | 21.7% | 18.1% | 16.9% | 16.7% | 18.9% |
| Interest Income | 70.59M | 91.49M | 124.92M | 137.24M | 149.95M |
| Interest Expense | 4.4M | 10.87M | 46.67M | 61.17M | 58.05M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 23.15M | 22.85M | 27.21M | 29.57M | 35.14M |
| Pre-Tax Margin | 21.7% | 18.1% | 16.9% | 16.7% | 18.9% |
| Income Tax Expense | 4.5M | 3.31M | 5.47M | 5.7M | 6.88M |
| Net Income | 18.66M | 19.54M | 21.75M | 23.87M | 28.25M |
| Net Margin | 17.5% | 15.4% | 13.5% | 13.5% | 15.2% |
| EPS (Basic) | 1.66 | 1.14 | 1.24 | 1.36 | 1.59 |
| EPS (Diluted) | 1.66 | 1.14 | 1.24 | 1.36 | 1.59 |
| Weighted Avg Shares | 11.25M | 17.19M | 17.58M | 17.56M | 17.79M |
| Weighted Avg Shares (Diluted) | 11.25M | 17.19M | 17.58M | 17.56M | 17.79M |
Colony Bankcorp, Inc.
NYSE:CBAN
Intrinsic Alpha fair value
Locked
Current Price
$19.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.